Literature DB >> 22042153

Nonlinear system identification by Gustafson-Kessel fuzzy clustering and supervised local model network learning for the drug absorption spectra process.

Luka Teslic1, Benjamin Hartmann, Oliver Nelles, Igor Skrjanc.   

Abstract

This paper deals with the problem of fuzzy nonlinear model identification in the framework of a local model network (LMN). A new iterative identification approach is proposed, where supervised and unsupervised learning are combined to optimize the structure of the LMN. For the purpose of fitting the cluster-centers to the process nonlinearity, the Gustafsson-Kessel (GK) fuzzy clustering, i.e., unsupervised learning, is applied. In combination with the LMN learning procedure, a new incremental method to define the number and the initial locations of the cluster centers for the GK clustering algorithm is proposed. Each data cluster corresponds to a local region of the process and is modeled with a local linear model. Since the validity functions are calculated from the fuzzy covariance matrices of the clusters, they are highly adaptable and thus the process can be described with a very sparse amount of local models, i.e., with a parsimonious LMN model. The proposed method for constructing the LMN is finally tested on a drug absorption spectral process and compared to two other methods, namely, Lolimot and Hilomot. The comparison between the experimental results when using each method shows the usefulness of the proposed identification algorithm.

Mesh:

Substances:

Year:  2011        PMID: 22042153     DOI: 10.1109/TNN.2011.2170093

Source DB:  PubMed          Journal:  IEEE Trans Neural Netw        ISSN: 1045-9227


  2 in total

1.  Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.

Authors:  R Wiest; Y Burren; M Hauf; G Schroth; J Pruessner; M Zbinden; K Cattapan-Ludewig; C Kiefer
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-11       Impact factor: 3.825

2.  Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.

Authors:  Roland Wiest; Jean-Marc Burgunder; Claus Kiefer
Journal:  Front Neurol       Date:  2017-09-06       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.